MIT’s wireless 'in-body GPS' may improve tumor monitoring, proton therapy

screen_shot_2018-08-20_at_3.09.28_pm.png

Courtesy of the Massachusetts Institute of Technology (MIT). 

Tracking tumors inside the body may become easier with the help of a newly developed “in-body GPS” called Remix, developed by researchers at the Massachusetts Institute of Technology (MIT)’s Computer Science and Artificial Intelligence Laboratory (CSAIL) in collaboration with Massachusetts General Hospital.